Skip to Main Content

Paper Details

Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results.
Clin Lymphoma Myeloma Leuk
5
2023
Author NameAffiliation
Gautam BorthakurUniversity of Texas MD Anderson Cancer Center
Guillermo Garcia-ManeroUniversity of Texas MD Anderson Cancer Center
Hagop KantarjianUniversity of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2